MCID: MYL001
MIFTS: 37

Myelitis malady

Categories: Rare diseases, Neuronal diseases

Aliases & Classifications for Myelitis

About this section

Aliases & Descriptions for Myelitis:

Name: Myelitis 10 45 47 12 36 65

Classifications:



External Ids:

Disease Ontology10 DOID:322
MeSH36 D009187
NCIt42 C26832
UMLS65 C0026975

Summaries for Myelitis

About this section
Wikipedia:68 Myelitis involves the infection or the inflammation of the white matter or gray matter of the spinal... more...

MalaCards based summary: Myelitis is related to idiopathic acute transverse myelitis and retinitis pigmentosa. An important gene associated with Myelitis is AQP4 (Aquaporin 4), and among its related pathways are Platelet Aggregation Inhibitor Pathway, Pharmacodynamics and MAP2K and MAPK activation. Affiliated tissues include spinal cord, brain and t cells, and related mouse phenotype vision/eye.

Related Diseases for Myelitis

About this section

Diseases related to Myelitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 602)
idRelated DiseaseScoreTop Affiliating Genes
1idiopathic acute transverse myelitis34.1APOA1, AQP4
2retinitis pigmentosa29.7APOH, MTHFR
3thyroid cancer29.0APOA1, APOH, ITGA2B, MTHFR
4neutropenia29.0AQP4, HLA-DPB1, MBP, MOG
5myocardial infarction28.6APOA1, APOH, ITGA2B, ITGB3, MTHFR
6transverse myelitis12.5
7acute transverse myelitis12.5
8secondary acute transverse myelitis12.5
9radiation myelitis12.3
10foix-alajouanine syndrome11.9
11neuromyelitis optica10.9
12encephalitis10.9
13acute disseminated encephalomyelitis10.8
14tropical spastic paraparesis10.5
15hashimoto's encephalitis10.4
16rasmussen subacute encephalitis10.4
17fatal post-viral neurodegenerative disorder10.4
18progressive encephalomyelitis with rigidity and myoclonus10.4
19autoimmune encephalopathy with parasomnia and obstructive sleep apnea10.4
20spinal cord disease10.3
21paresthesia10.3
22nephrolithiasis10.3AQP4, MTHFR
23spinocerebellar atrophy10.3APOH, MTHFR
24hepatitis10.3
25liver failure acute infantile10.3APOH, MTHFR
26catatrichy10.3APOH, MTHFR
27pregnancy loss, recurrent 110.3APOH, MTHFR
28leukemia10.3
29malignant hypertensive renal disease10.3AQP4, MOG
30sesame syndrome10.2APOH, MTHFR
31maple bark strippers' lung10.2APOH, MTHFR
32ischemic optic neuropathy10.2APOA1, ITGB3
33meningoencephalitis10.2
34lymphoma10.2
35neuronitis10.2
36bubonic plague10.2APOH, ITGB3
37eccrine sweat gland neoplasm10.2APOH, MTHFR
38colonic pseudo-obstruction10.2APOH, MTHFR
39obesity10.2
40endotheliitis10.2
41vertebral artery insufficiency10.2APOH, MTHFR
42multiple epiphyseal dysplasia10.2APOA1, MTHFR
43withdrawal disorder10.2APOH, ITGB3
44oral squamous cell carcinoma10.2ITGB3, MTHFR
45protein s deficiency10.2APOH, MTHFR
46pyridoxamine 5'-phosphate oxidase deficiency10.2ITGA2B, ITGB3
47fetal antihypertensive drugs syndrome10.2ITGA2B, ITGB3
48short stature due to primary acid-labile subunit deficiency10.2ITGA2B, ITGB3
49nutmeg liver10.2APOH, MTHFR
50colorectal cancer10.2

Graphical network of the top 20 diseases related to Myelitis:



Diseases related to myelitis

Symptoms for Myelitis

About this section

Drugs & Therapeutics for Myelitis

About this section

Drugs for Myelitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 129)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Mitoxantroneapproved, investigationalPhase 425765271-80-94212
Synonyms:
1,4-Bis(2-(2-hydroxyethylamino)ethyl)amino)-5,8-dihydroxyanthraquinone
1,4-DIHYDROXY-5,8-BIS({2-[(2-HYDROXYETHYL)AMINO]ETHYL}AMINO)-9,10-ANTHRACENEDIONE
1,4-DIHYDROXY-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)-9,10-anthracenedione
1,4-Dihydroxy-5,8-bis(2-((2-hydroxyethyl)amino)ethylamino)-9,10-anthracenedione
1,4-Dihydroxy-5,8-bis(5-hydroxy-3-azapentylamino)anthrachinon
1,4-Dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione
1,4-Dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]-9,10-anthracenedione
1,4-dihydroxy-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)anthra-9,10-quinone
1,4-dihydroxy-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)anthracene-9,10-dione
137635-96-2
2fum
5,8-Bis((2-((2-hydroxyethyl)amino)ethyl)amino)-1,4-dihydroxyanthraquinone
65271-80-9
70476-82-3
70476-82-3 (hydrochloride)
70711-41-0
70711-41-0 (acetate)
70945-62-9
9,10-Anthracenedione, 1,4-dihydroxy-5,8-bis((2-((2-hydroxyethyl)amino)ethyl)amino)- (9CI)
AB00053716
AC1L1HNY
AN-584/42007670
BIDD:PXR0181
BPBio1_000627
BRD-K21680192-300-05-2
BRD-K21680192-300-07-8
BRN 2795126
BSPBio_000569
BSPBio_003160
C11195
C22H28N4O6
CAS-70476-82-3
CCRIS 7604
CHEBI:50729
CHEMBL58
CID4212
D08224
DB01204
DHAD
DHAQ
DHAQ (*Diacetate salt*)
DHAQ HCl
Dihydroxyanthraquinone
DivK1c_000516
HMS2090D05
IDI1_000516
KBio1_000516
KBio2_002135
KBio2_004703
KBio2_007271
KBio3_002660
KBioGR_001531
KBioSS_002135
LS-20638
Liposome Encapsulated Mitoxantrone (LEM)
Lopac-M-6545
Lopac0_000779
MITOXANTRONE, 1,4-DIHYDROXY-5,8-BIS({2-[(2-HYDROXYETHYL)AMINO]ETHYL}AMINO)ANTHRA-9,10-QUINONE
MITOXANTRONE, Mitoxantrone Hydrochloride, Mitoxantrone dihydrochloride, MITOXANTHRONE HYDROCHLORIDE
MIX
MLS002703044
 
Misostol
Misostol (TN)
Mitox
Mitoxanthrone
Mitoxantron
Mitoxantrona
Mitoxantrona [INN-Spanish]
Mitoxantrone
Mitoxantrone (INN)
Mitoxantrone (free base)
Mitoxantrone 2HCl
Mitoxantrone HCl
Mitoxantrone Hydrochloride
Mitoxantrone [INN]
Mitoxantrone dihydrochloride
Mitoxantrone hydrochloride
Mitoxantronum
Mitoxantronum [INN-Latin]
Mitozantrone
Mitozantrone hydrochloride
MolPort-003-849-239
NCGC00015693-01
NCGC00015693-02
NCGC00015693-04
NCGC00162251-01
NCI60_002276
NCI60_002535
NChemBio.2007.10-comp17
NINDS_000516
NSC 279836
NSC-279836
NSC-287836
NSC-299195
NSC-301739
NSC-301739D
NSC279836
NSC299195
NSC301739
Neuro_000153
Novantron
Novantrone
Novantrone(R) (mitoxantrone for injection concentrate)
Prestwick0_000385
Prestwick1_000385
Prestwick2_000385
Prestwick3_000385
S2485_Selleck
SMP2_000179
SMR001549953
SPBio_000756
SPBio_002490
SR-01000076001
SR-01000076001-7
STK631833
Spectrum2_000908
Spectrum3_001590
Spectrum4_000866
Spectrum5_001205
Spectrum_001655
UNII-BZ114NVM5P
VU0244399-2
mitoxantrone
2
MethylprednisoloneapprovedPhase 4, Phase 3, Phase 1, Phase 2108283-43-26741
Synonyms:
(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
(6a,11b)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6α,11β)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione
.DELTA.1-6.alpha.-Methylhydrocortisone
1-Dehydro-6alpha-methylhydrocortisone
1-dehydro-6alpha-Methylhydrocortisone
1-dehydro-6α-methylhydrocortisone
11-beta,17,21-Trihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione
11beta,17,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methyl-1,4-pregnadiene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
121673-01-6
4-08-00-03498 (Beilstein Handbook Reference)
46436_FLUKA
46436_RIEDEL
570-35-4
6 Methylprednisolone
6-Methylprednisolone
6-alpha-Methylprednisolone
6.alpha.-Methylprednisolone
6923-42-8
6alpha-Methyl-11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione
6alpha-Methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
6alpha-Methylprednisolone
6alpha-methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
83-43-2
A-methapred
AC1L1N7A
Artisone-Wyeth
Artisone-wyeth
BPBio1_000174
BRD-K35240538-001-03-1
BRN 2340300
BSPBio_000158
Besonia
Bio-0658
CHEBI:6888
CHEMBL650
CID6741
CPD000058330
D00407
D008775
DB00959
Depo-Medrol (acetate)
Depo-medrol
Dopomedrol
EINECS 201-476-4
Esametone
Firmacort
HMS1568H20
HMS2090B13
HSDB 3127
LMST02030178
LS-118498
Lemod
M0639_SIGMA
M1665
MEPRDL
MLS000028541
MLS001148159
MLS002207191
Medesone
Medixon
Medlone 21
 
Medrate
Medrol
Medrol (TN)
Medrol Adt Pak
Medrol Dosepak
Medrol adt pak
Medrol dosepak
Medrol, Solu-Medrol, Medrone, Methylprednisolone
Medrone
Mesopren
Metastab
Methyleneprednisolone
Methylprednisolon
Methylprednisolone
Methylprednisolone (JP15/USP/INN)
Methylprednisolone [USAN:INN:BAN:JAN]
Methylprednisolone, 6-alpha
Methylprednisolonum
Methylprednisolonum [INN-Latin]
Metilbetasone
Metilprednisolona
Metilprednisolona [INN-Spanish]
Metilprednisolone
Metilprednisolone [DCIT]
Metilprednisolone [Dcit]
Metipred
Metrisone
Metrocort
Metysolon
Moderin
MolPort-002-528-554
NCGC00022735-03
NCI60_001657
NSC-19987
NSC19987
Nirypan
Noretona
Predni N Tablinen
Prednol- L
Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-6alpha-methyl- (8CI)
Prestwick0_000279
Prestwick1_000279
Prestwick2_000279
Prestwick3_000279
Prestwick_622
Promacortine
Reactenol
S1733_Selleck
SAM002589984
SMR000058330
SPBio_002377
Sieropresol
Solomet
Solu-medrol
Summicort
Suprametil
U 7532
UNII-X4W7ZR7023
Urbason
Urbasone
Wyacort
ZINC03875560
delta(1)-6alpha-Methylhydrocortisone
delta(sup 1)-6-alpha-Methylhydrocortisone
methylprednisolone
methylprenisolone
3
PrednisoloneapprovedPhase 4, Phase 3, Phase 1, Phase 2108250-24-85755
Synonyms:
(11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione
.DELTA.1-Cortisol
.DELTA.1-Dehydrocortisol
.DELTA.1-Dehydrohydrocortisone
.DELTA.1-Hydrocortisone
.delta.-Cortef
.delta.-Stab
1,2-Dehydrohydrocortisone
1,4-Pregnadiene-11beta,17alpha,21-triol-3,20-dione
1,4-Pregnadiene-3,20-dione-11beta,17alpha,21-triol
1-Dehydrocortisol
1-Dehydrohydrocortisone
3,20-dioxo-11beta,17alpha,21-Trihydroxy-1,4-pregnadiene
46656_FLUKA
46656_RIEDEL
50-24-8
58201-11-9
8056-11-9
AC-1773
AC1L1L2E
Ak-Pred
Ak-Tate
Alphadrol
Articulose-50
BPBio1_000164
BRD-K98039984-001-03-0
BRN 1354103
BSPBio_000148
Bio-0666
Bubbli-Pred
C07369
CCRIS 980
CHEBI:8378
CHEMBL131
CID5755
CO-Hydeltra
CPD000718761
Co-Hydeltra
Codelcortone
Cordrol
Cortalone
Cotogesic
Cotolone
D00472
D011239
DB00860
Decaprednil
Decortin H
Delcortol
Delta F
Delta(1)-dehydrohydrocortisone
Delta-Cortef
Delta-Cortef (TN)
Delta-Ef-Cortelan
Delta-Stab
Delta-stab
Deltacortenol
Deltacortril
Deltacortril Enteric
Deltahydrocortisone
Deltasolone
Deltisilone
Depo-Medrol
Derpo PD
Derpo Pd
Dexa-Cortidelt Hostacortin H
Dexa-Cortidelt hostacortin H
Di Adreson F
Di-Adreson F
Di-Adreson-F
Di-adreson F
DiAdresonF
Dicortol
Donisolone
Dydeltrone
EINECS 200-021-7
Eazolin D
Econopred
Econopred Plus
Erbacort
Erbasona
Estilsona
Fernisolone
Fernisolone P
Fernisolone-P
Flamasone
Flo-pred
HMS1568H10
HMS2090J05
HSDB 3385
Hostacortin H
Hydeltra
Hydeltra-Tba
Hydeltrasol
Hydeltrone
Hydrodeltalone
Hydrodeltisone
Hydroretrocortin
Hydroretrocortine
I-Pred
Inflamase Forte
Inflamase Mild
K 1557
Key-Pred
Klismacort
LMST02030179
LS-7669
Lentosone
Lite Pred
M-Predrol
MLS001304083
 
MLS002154250
MLS002207037
Medrol
Medrol Acetate
Metacortandralone
Methylprednisolone Acetate
Meti-Derm
Meticortelone
Metreton
Millipred
MolPort-002-507-147
NCGC00179649-01
NSC 9120
NSC9120
NSC9900
Neo-Delta-Cortef
Nisolone
Nor-Pred T.B.A.
Ocu-Pred
Ocu-Pred Forte
Omnipred
Ophtho-Tate
Orapred
P0152_SIGMA
P0637
P6004_SIGMA
PRDL
PRED-G
Panafcortelone
Paracortol
Paracotol
Pediapred
Poly-Pred
Precortalon
Precortancyl
Precortilon
Precortisyl
Pred Forte
Pred Mild
Predair
Predair A
Predair Forte
Predalone 50
Predalone T.B.A.
Predate
Predate Tba
Predate-50
Predcor-25
Predcor-50
Predcor-Tba
Predisolone Sodium Phosphate
Predne-Dome
Prednelan
Predni-Dome
Prednicen
Predniliderm
Predniretard
Prednis
Prednisolona
Prednisolona [INN-Spanish]
Prednisolone
Prednisolone (JP15/USP/INN)
Prednisolone (anhydrous)
Prednisolone Acetate
Prednisolone Sodium Phosphate
Prednisolone Tebutate
Prednisolone [INN:BAN:JAN]
Prednisolonum
Prednisolonum [INN-Latin]
Predonin
Predonine
Prelone
Prenolone
Prestwick0_000274
Prestwick1_000274
Prestwick2_000274
Prestwick3_000274
Prestwick_404
Rolisone
S1737_Selleck
SAM002264639
SMR000718761
SPBio_002367
Scherisolon
Solone
Steran
Sterane
Sterolone
Supercortisol
UNII-9PHQ9Y1OLM
Ulacort
Ultra Pred
Ultracorten H
Ultracortene H
Ultracortene-H
Ultracortene-Hydrogen
Ultracortene-hydrogen
ZINC03833821
component of Ataraxoid
component of K-Predne-Dome
delta(1)-Cortisol
delta(1)-Dehydrocortisol
delta(1)-Dehydrohydrocortisone
delta(1)-Hydrocortisone
delta(sup 1)-Cortisol
delta(sup 1)-Dehydrocortisol
delta(sup 1)-Dehydrohydrocortisone
delta(sup 1)-Hydrocortisone
delta-dehydrocortisol
delta-dehydrohydrocortisone
delta-hydrocortisone
prednisolone
4
Interferon beta-1aapproved, investigationalPhase 4, Phase 2194145258-61-36438354
Synonyms:
145258-61-3
Avonex
Avonex (TN)
Avonex Pen
Belerofon
D04554
Extavia
 
Fibroblast interferon
IFN-beta
Interferon beta precursor
Interferon beta-1a
Interferon beta-1a (USAN)
Interferon beta-1a (genetical recombination)
Interferon beta-1a (genetical recombination) (JAN)
Rebif
Rebif Rebidose
5
ZincapprovedPhase 414777440-66-623994, 32051
Synonyms:
30Zn
Cinc
Zinc
Zinc ion
 
Zincum
Zink
Zn
Zn(ii)
Zn2+
6
DalfampridineapprovedPhase 4, Phase 262504-24-51727
Synonyms:
.gamma.-Aminopyridine
275875_ALDRICH
36687_FLUKA
36687_RIEDEL
4 AP
4 Aminopyridine
4 Aminopyridine Sustained Release
4-AP
4-Aminopyridine
4-Aminopyridine 10
4-Aminopyridine Sustained Release
4-Pyridinamine
4-Pyridylamine
4-aminopyridine
5-22-09-00106 (Beilstein Handbook Reference)
504-24-5
A 0152
A0414
A78403_ALDRICH
AB1004971
AC-907/25014071
AC1L1C3R
AC1Q52BM
AI3-52547
AKOS000119896
Amaya
Amino-4 pyridine
Amino-4-Pyridine
Ampydin
Ampyra
Avitrol
Avitrol 200
BB_SC-6974
BRN 0105782
BSPBio_001562
Bio1_000353
Bio1_000842
Bio1_001331
Bio2_000282
Bio2_000762
C13728
C5H6N2
CHEBI:34385
CHEMBL284348
CID1727
Caswell No. 038
Compound 1861
D015761
D04127
Dalfampridine
DivK1c_000572
EINECS 207-987-9
EL-970
EPA Pesticide Chemical Code 069201
EU-0100032
FT-0083754
Fampridina
Fampridine
Fampridine (USAN/INN)
Fampridine SR
Fampridine [USAN:INN]
Fampridine-PR
Fampridine-SR
Fampridinum
Fampyra
HC150041
HMS1361O04
HMS1791O04
HMS1921H15
HMS1989O04
HMS2092F05
HMS501M14
HSDB 6037
IDI1_000572
IDI1_034032
InChI=1/C5H6N2/c6-5-1-3-7-4-2-5/h1-4H,(H2,6,7
 
KBio1_000572
KBio2_000282
KBio2_000635
KBio2_002850
KBio2_003203
KBio2_005418
KBio2_005771
KBio3_000563
KBio3_000564
KBio3_001888
KBioGR_000282
KBioGR_001505
KBioSS_000282
KBioSS_000635
LS-130202
Lopac-A-0152
Lopac0_000032
MLS000069400
Mi-W-3
MolPort-000-146-022
N07XX07
NCGC00015009-01
NCGC00015009-03
NCGC00015009-12
NCGC00024890-01
NCGC00024890-02
NCGC00024890-03
NCGC00024890-04
NCGC00024890-05
NCGC00024890-06
NCGC00024890-07
NCGC00024890-08
NCGC00024890-09
NCGC00024890-10
NINDS_000572
NSC 15041
NSC15041
Neurelan
Neurelan (TN)
P-Aminopyridine
PYRIDINE,4-AMINO
Philips 1861
Phillips 1861
Pimadin (free base)
Prc 1237
Pymadin
Pymadine
RCRA waste no. P008
SDCCGMLS-0066228.P001
SMR000058211
SPBio_001486
SPECTRUM1501130
STK298717
Spectrum2_001413
Spectrum3_000914
Spectrum4_001013
Spectrum5_001501
Spectrum_000155
Sustained Release, 4-Aminopyridine
TL8003344
Tocris-0940
UNII-BH3B64OKL9
UPCMLD-DP125
UPCMLD-DP125:001
VMI 10-3
VMI 103
VMI-10-3
VMI-103
VMI103
WLN: T6NJ DZ
[J.Pharmacol.Exp.Ther. 275:864 (1995)]
gamma-Aminopyridine
nchem.892-comp4
p-Aminopyridine
p-Aminopyridine [UN2671] [Poison]
p-Aminopyridine [UN2671] [Poison]
pyridin-4-amine
pyridin-4-ylamine
7
NeomycinapprovedPhase 4421404-04-28378
Synonyms:
(1R,2R,3S,4R,6S)-4,6-diamino-2-{[3-O-(2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl)-beta-D-ribofuranosyl]oxy}-3-hydroxycyclohexyl 2,6-diamino-2,6-dideoxy-alpha-D-glucopyranoside
(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol
11025-81-3
119-04-0
1393-86-8
1404-04-2
1405-10-3 (sulfate (salt))
4-18-00-07476 (Beilstein Handbook Reference)
72131_FLUKA
AB00443887
AC1L1QVH
Actilin
Actiline
Antibiotic 10676
Antibiotic produced by Streptomyces decaris. Neomycin B
Antibiotique
BDG-(1-4)CYY-(5-1)RIB-(3-1)IDG
BDG-(1-4)NEB-(5-1)RIB-(3-1)NED
BPBio1_000326
BRN 0101621
BSPBio_000296
C01737
C23H46N6O13
C25H50N6O13
CCRIS 5462
CHEBI:7508
CID8378
Caswell No. 595
D-Streptamine, O-2,6-diamino-2,6-dideoxy-.beta.-L-idopyranosyl-(1.->3)-O-.beta.-D-ribofuranosyl-(1->5)]-O-[2,6-diamino-2,6-dideoxy-.alpha.-D-glucopyranosyl-(1->4)]-2-deoxy
D05140
DB00452
DB00994
EINECS 204-292-2
EINECS 215-766-3
EPA Pesticide Chemical Code 006303
Endomixin
Enterfram
Fradiomycin
Fradiomycin B
Fradiomycinum
Framicetina
Framicetina [INN-Spanish]
Framycetin
Framycetin (INN)
Framycetin [INN:BAN:DCF]
Framycetine
Framycetine [INN-French]
Framycetinum
Framycetinum [INN-Latin]
Framygen
 
Fraquinol
HMS2089P15
HSDB 3242
LS-96091
LS-96095
MolPort-003-938-736
Myacine
Myacyne
Mycifradin
Myciguent
N1142_SIGMA
NCGC00179612-01
NEOMYCIN AND POLYMYXIN B SULFATES
NEOMYCIN B
NEOMYCIN SULFATE
NMY
Neo-Fradin
Neo-Rx
Neo-fradin
Neobiotic
Neobrettin
Neolate
Neomas
Neomcin
Neomicina
Neomicina [DCIT]
Neomin
Neomycin B Sulfate
Neomycin B sulfate
Neomycin Sulfate
Neomycin Sulphate
Neomycin solution
Neomycine
Neomycine [INN-French]
Neomycinum
Neomycinum [INN-Latin]
Nivemycin
PIMAVECORT
Prestwick3_000158
ST075177
Soframycin
Soframycin Ophthalmic
Soframycine
Theraplusplus Plus
Tuttomycin
UNII-4BOC774388
UNII-I16QD7X297
USAF CB-19
VONAMYCIN
Vonamycin powder V
neomycin
8
Phenolapproved, experimentalPhase 443108-95-2996
Synonyms:
Acide carbolique
Acide phenique
Anbesol
Aseptil Rojo
Benzenol
Benzophenol
Campho-phenique cold sore gel
Campho-phenique gel
Campho-phenique liquid
Carbolic acid
Carbolic acid liquid
Carbolic oil
Carbolicum acidum
Carbolsaeure
Carbolsaure
Care One Sore Throat
Castellani Paint
Castellani Paint 1.5%
Cepastat Cherry
Cepastat Extra Strength
Cepastat lozenges
Chloraseptic Sore Throat
Chloraseptic Sore Throat Cherry
Chloraseptic Sore Throat Citrus
Chloraseptic Sore Throat Menthol
Chloraseptic Warming Sore Throat
Cuticura pain relieving ointment
Dg Health Sore Throat
Equaline Sore Throat
Equate Sore Throat
Fenol
Fenolo
Fenosmolin
Fenosmoline
Good Neighbor Pharmacy Sore Throat
Good Sense Sore Throat
Healthy Accents Sore Throat
Hydroxy-benzene
Hydroxybenzene
IPH
IZAL
Karbolsaeure
Leader Sore Throat
Liquefied phenol
Liquid phenol
 
Liquified phenol
Monohydroxy benzene
Monohydroxybenzene
Monophenol
Oral Relief
Oxybenzene
PHOH
Paoscle
Phenic
Phenic Acid
Phenic acid
Phenic alcohol
Phenol
Phenol alcohol
Phenol homopolymer
Phenol liquid
Phenol molten
Phenol polymer-bound
Phenol solution
Phenol synthetic
Phenolated water
Phenolated water for disinfection
Phenole
Phenosmolin
Phenyl alcohol
Phenyl hydroxide
Phenylic Acid
Phenylic acid
Phenylic alcohol
Rx Act Sore Throat
Smart Sense Sore Throat
Sore Throat
Sore Throat Cherry
Sore Throat Menthol
Sore Throat ReadyInCase
Sore Throat Relief
Sore Throat Relief Cherry
Sore Throat Spray
Sore Throat Spray Cherry
Sore Throat cherry
Sore Throat spray
Sunmark Sore Throat
Synthetic phenol
Tea polyphenol
Throat Relief
Topcare Sore Throat
9Trace ElementsPhase 43900
10Nucleic Acid Synthesis InhibitorsPhase 4, Phase 2, Phase 3, Phase 03836
11Zinc SulfatePhase 464
12Immunosuppressive AgentsPhase 4, Phase 2, Phase 3, Phase 110422
13MicronutrientsPhase 43901
14VaccinesPhase 4, Phase 3, Phase 2, Phase 16085
15Interferon-betaPhase 4, Phase 2253
16Adjuvants, ImmunologicPhase 4, Phase 21783
17PENTAPhase 4, Phase 3109
18AntimetabolitesPhase 4, Phase 2, Phase 3, Phase 09454
19Antirheumatic AgentsPhase 4, Phase 2, Phase 3, Phase 18496
20Dermatologic AgentsPhase 4, Phase 2, Phase 34555
21Pharmaceutical SolutionsPhase 4, Phase 3, Phase 2, Phase 17004
22Heptavalent Pneumococcal Conjugate VaccinePhase 4, Phase 3, Phase 2440
23ImmunoglobulinsPhase 4, Phase 3, Phase 2, Phase 14477
24Prednisolone phosphatePhase 4, Phase 3, Phase 1, Phase 21082
25AntibodiesPhase 4, Phase 3, Phase 2, Phase 14477
26Protective AgentsPhase 4, Phase 3, Phase 15651
27AntiemeticsPhase 4, Phase 3, Phase 13213
28Anti-Inflammatory AgentsPhase 4, Phase 3, Phase 18478
29Antineoplastic Agents, HormonalPhase 4, Phase 3, Phase 14256
30Prednisolone hemisuccinatePhase 4, Phase 3, Phase 1, Phase 21082
31Topoisomerase InhibitorsPhase 44081
32Peripheral Nervous System AgentsPhase 4, Phase 3, Phase 118510
33interferonsPhase 4, Phase 21930
34AnalgesicsPhase 49358
35Immunologic FactorsPhase 4, Phase 3, Phase 2, Phase 118483
36glucocorticoidsPhase 4, Phase 3, Phase 13896
37Gastrointestinal AgentsPhase 4, Phase 3, Phase 2, Phase 16401
38Methylprednisolone HemisuccinatePhase 4, Phase 3, Phase 1, Phase 21082
39Neuroprotective AgentsPhase 4, Phase 3, Phase 11376
40Anti-Infective AgentsPhase 4, Phase 2, Phase 3, Phase 017220
41Prednisolone acetatePhase 4, Phase 3, Phase 1, Phase 21082
42Hormone AntagonistsPhase 4, Phase 3, Phase 110002
43Methylprednisolone acetatePhase 4, Phase 3, Phase 1, Phase 21082
44Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 4, Phase 3, Phase 19988
45HormonesPhase 4, Phase 3, Phase 111748
46Antiviral AgentsPhase 4, Phase 2, Phase 3, Phase 08071
47Potassium Channel BlockersPhase 4, Phase 2151
48Contraceptives, OralPhase 4, Phase 23734
49PolymyxinsPhase 450
50Polymyxin BPhase 436

Interventional clinical trials:

(show top 50)    (show all 192)
idNameStatusNCT IDPhase
1Long Term Study of Avonex Therapy Following a First Attack of Multiple SclerosisCompletedNCT00179478Phase 4
2A Pilot Study of Mitoxantrone for the Treatment of Recurrent Neuromyelitis Optica (Devic’s Disease)CompletedNCT00304291Phase 4
3Oral Corticotherapy in Megadoses to Treat Multiple Sclerosis During RelapseCompletedNCT00753792Phase 4
4Immunogenicity of Monovalent Type 2 Oral Poliovirus VaccineCompletedNCT02643368Phase 4
5Polio End-game Strategies - Poliovirus Type 2 Challenge StudyCompletedNCT02189811Phase 4
6Study of IMOVAX POLIO® Subcutaneous as a Booster Vaccine in Pre-school Age Children in JapanCompletedNCT02005536Phase 4
7IPV Clinical Trial - The GambiaCompletedNCT01847872Phase 4
8Safety and Immunogenicity of 1 or 2 Doses of IPV in Latin American Infants Primed With Bivalent OPV VaccineCompletedNCT01831050Phase 4
9Zinc and/or Probiotic Supplementation of Rotavirus and Oral Polio Virus VaccinesCompletedNCT01616693Phase 4
10Antibody Persistence to REVAXIS or DT Polio and Immune Response to TETRAVAC-ACELLULAIRECompletedNCT01546909Phase 4
11Sequential Inactivated Poliomyelitis Vaccine Followed by Oral Poliomyelitis Vaccine Versus Oral Poliomyelitis VaccineCompletedNCT01475539Phase 4
12Comparison of Immunogenicity and Reactogenicity of INFANRIX™ HEXA and HEXAVAC™ Vaccines as a Primary Vaccination CourseCompletedNCT01457547Phase 4
13Regulatory Post-Marketing Surveillance Study for TETRAXIM™CompletedNCT01437423Phase 4
14Study to Evaluate Antibody Persistence in Children Previously Vaccinated With Infanrix Hexa™ or Infanrix-IPV/Hib™CompletedNCT01358825Phase 4
15Immunogenicity and Safety of Booster Dose of BoostrixTM Polio Vaccine in Previously Boosted AdultsCompletedNCT01323959Phase 4
16A Safety Study of IMOVAX Polio Vaccine in Selected Cities in ChinaCompletedNCT01278433Phase 4
17A Study of the Safety of IMOVAX Polio™ in ChinaCompletedNCT01244464Phase 4
18Study to Evaluate the Safety of Co-administration of GSK Biologicals' Poliorix and Infanrix in Healthy Children in RussiaCompletedNCT01094171Phase 4
19Immunogenicity and Safety of TETRAXIM™ Given as a Booster Dose at 4 to 6 Years of AgeCompletedNCT01031303Phase 4
20Immunogenicity and Safety of GSK Biologicals' Infanrix Hexa in InfantsCompletedNCT00753649Phase 4
21Safety and Immunogenicity of a Booster Dose of GSK Biological's Boostrix-Polio VaccineCompletedNCT00635128Phase 4
22Study of a New Formulation of DTPa-HBV-IPV/Hib Vaccine Administered as a Booster Dose to 18-23 Months Old ChildrenCompletedNCT00611559Phase 4
23Immunogenicity and Safety Study of a Booster Dose (5th) of Diphteria-Tetanus-Pertussis-Polio VaccineCompletedNCT00514059Phase 4
24Assess the Safety & Reactogenicity of DTPa-IPV/Hib Vaccine Administered at 3, 4, 5 & 18 Mths of Age, in Healthy InfantsCompletedNCT00325156Phase 4
25Post-marketing Evaluation of Reactions Following Receipt of Recommended Adolescent Pertussis VaccineCompletedNCT00304265Phase 4
26Immunogenicity and Safety of Sanofi Pasteur Pentaxim Combined Vaccine in Infants in ThailandCompletedNCT00255021Phase 4
27Serological Survey on Monitoring the Positive Rate After Vaccination of Inactivated Polio VaccineRecruitingNCT02643446Phase 4
28Immunogenicity and Safety Study of Infanrix Hexa in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-deliveryRecruitingNCT02422264Phase 4
29To Develop, Implement and Evaluate the Polio Demonstration Project Comprising of a Community Based Intervention Package for Polio Eradication in PakistanRecruitingNCT01908114Phase 4
30Efficacy and Safety of Mitoxantrone in Patients With Refractory Neuromyelitis Optica and Spectrum DisordersRecruitingNCT02021825Phase 4
31Intestinal and Humoral Immunity of Sequential Polio Vaccination SchedulesActive, not recruitingNCT02412514Phase 4
32A Study to Evaluate the Safety and Immunogenicity of Monovalent OPV2 in Children Aged 1 to 5 Years in LithuaniaNot yet recruitingNCT02582255Phase 4
33A Study to Evaluate Safety and Immunogenicity of tOPV in 1 to 5 Years and at 6 Weeks of AgeNot yet recruitingNCT02580201Phase 4
34Safety and Efficacy of Sustained Release Dalfampridine in Transverse MyelitisTerminatedNCT01446575Phase 4
35Induction Therapy With a Single High Dose Bolus of Intravenous Methotrexate With Leucovorin Rescue, Prior to Initiation of AVONEX® Treatment, in Patients Presenting With a First Acute Demyelinating Event.WithdrawnNCT00037115Phase 4
36Additional 6-Month Safety Follow-up After Completion of Precursor Study 880801CompletedNCT01604746Phase 3
37Immunogenicity of Intramuscular Inactivated Poliovirus VaccineCompletedNCT02291263Phase 3
38The Immunogenicity and Safety of Live Attenuated Poliomyelitis Vaccine (Human Diploid Cell)CompletedNCT02231632Phase 2, Phase 3
39Antibody Persistence at Age 3.5 and 4.5 Years After Primary and Booster DTaP-IPV-Hep B-PRP~T or Infanrix Hexa VaccinationCompletedNCT01983540Phase 3
40Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine in Indian Infants Previously Given a Dose of Hepatitis B Vaccine at BirthCompletedNCT01948193Phase 3
41Immunogenicity of Inactivated and Live Polio VaccinesCompletedNCT01813604Phase 3
42Safety of GSK Biologicals' Infanrix-IPV+HibTM Vaccine in Healthy Vietnamese ToddlersCompletedNCT01577732Phase 3
43Intravenous Immunoglobulins for Post-Polio SyndromeCompletedNCT01537575Phase 3
44The Clinical Trial Protocol for the Inactivated Poliomyelitis Vaccine Made From Sabin Strains(Sabin IPV)CompletedNCT01510366Phase 3
45Use of Pentoxifylline in Human T-lymphotropic Virus Type-1 (HTLV-1) DiseasesCompletedNCT01472263Phase 3
46Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib Vaccine Followed by the Same Vaccine and Oral Polio VaccineCompletedNCT01457560Phase 3
47Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib, Compared to DTPa-HBV-IPV and Hib Administered SeparatelyCompletedNCT01457508Phase 3
48Study of the Booster Effect of DTaP-IPV-Hep B-PRP~T Combined Vaccine or Infanrix Hexa™ and Prevenar™ in Healthy InfantsCompletedNCT01444781Phase 3
49Study of SP059 Given Subcutaneously as a Three-dose Primary and Booster Vaccination in Infants in JapanCompletedNCT01389687Phase 3
50Immunogenicity and Safety Study in Infants of GlaxoSmithKline Biologicals' Infanrix Hexa™ (DTPa-HBV-IPV/Hib) VaccineCompletedNCT01353703Phase 3

Search NIH Clinical Center for Myelitis


Cochrane evidence based reviews: myelitis

Genetic Tests for Myelitis

About this section

Anatomical Context for Myelitis

About this section

MalaCards organs/tissues related to Myelitis:

33
Spinal cord, Brain, T cells, Breast, Lung, Endothelial, Myeloid

Animal Models for Myelitis or affiliated genes

About this section

MGI Mouse Phenotypes related to Myelitis:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053917.8AQP4, ITGB3, MBP, MOG, MTHFR

Publications for Myelitis

About this section

Articles related to Myelitis:

(show top 50)    (show all 837)
idTitleAuthorsYear
1
Nephrogenic Adenoma: Clinical Features, Management, and Diagnostic Pitfalls. (27138263)
2016
2
Tooth resorption in cats: Pathophysiology and treatment options. (25527492)
2015
3
Expression of carbonic anhydrase 9 is a novel prognostic marker in resectable hepatocellular carcinoma. (25577552)
2015
4
Interferon-inducible guanylate binding protein (GBP2) is associated with better prognosis in breast cancer and indicates an efficient T cell response. (23001506)
2014
5
Quadrupedal head position enhances recovery from chronic maxillary sinusitis. (23731852)
2013
6
Effective inhibition of skin cancer, tyrosinase, and antioxidative properties by astaxanthin and astaxanthin esters from the green alga Haematococcus pluvialis. (23473626)
2013
7
Target gene repression mediated by miRNAs miR-181c and miR-9 both of which are down-regulated by amyloid-I^. (21720722)
2012
8
Six months treatment with ibopamine in patients with hypotony after vitreoretinal surgery for retinal detachment, uveitis or penetrating trauma. (21909052)
2012
9
Association analysis between polymorphisms in the dopamine D2 receptor (DRD2) and dopamine transporter (DAT1) genes with cocaine dependence. (20170711)
2010
10
Chromogranin A as a crucial factor in the sorting of peptide hormones to secretory granules. (21046450)
2010
11
Photoreceptor atrophy in acute zonal occult outer retinopathy. (18547281)
2008
12
Thr11 phosphorylated H3 is associated with centromere DNA during mitosis in MCF-7 cells. (18163200)
2008
13
A novel dendritic cell-based cancer vaccine produces promising results in a syngenic CC-36 murine colon adenocarcinoma model. (17275030)
2007
14
Anti-interleukin 8 autoantibody:interleukin 8 immune complexes visualized by laser confocal microscopy in injured lung. (17516748)
2007
15
Mechanisms of genotoxicity of nucleoside reverse transcriptase inhibitors. (16395695)
2007
16
Hydration of vinyl ether groups by unsaturated glycoside hydrolases and their role in bacterial pathogenesis. (18228220)
2007
17
Ameloblastic carcinoma of the maxilla: case report and review of the literature. (17942338)
2007
18
PADI4 polymorphisms and rheumatoid arthritis susceptibility: a meta-analysis. (17265154)
2007
19
Immunogenicity and safety of pneumococcal 7-valent conjugate vaccine (diphtheria CRM(197) protein conjugate; Prevenar ) in Korean infants: differences that are found in Asian children. (17931753)
2007
20
Increasing sulfatide synthesis in myelin-forming cells of arylsulfatase A-deficient mice causes demyelination and neurological symptoms reminiscent of human metachromatic leukodystrophy. (17728461)
2007
21
Conditional expression of human acid beta-glucosidase improves the visceral phenotype in a Gaucher disease mouse model. (16861620)
2006
22
Diagnostic value and prognostic implications of serum procalcitonin after cardiac surgery: a systematic review of the literature. (17038199)
2006
23
Gene frequencies of human platelet antigens in the Macedonian population. (16573563)
2006
24
Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. (16831965)
2006
25
Umbilical cord levels of interleukin-1 receptor antagonist and neonatal outcome. (16301842)
2006
26
Antiviral and immunoregulatory effect of a novel exopolysaccharide from a marine thermotolerant Bacillus licheniformis. (16332508)
2006
27
beta Subunits of voltage-gated sodium channels are novel substrates of beta-site amyloid precursor protein-cleaving enzyme (BACE1) and gamma-secretase. (15824102)
2005
28
Hedgehog signaling in normal urothelial cells and in urothelial carcinoma cell lines. (15521068)
2005
29
Cytochrome c, an ideal antioxidant. (14641051)
2003
30
Rhinovirus is associated with severe asthma exacerbations and raised nasal interleukin-12. (11961427)
2002
31
Effect of intravenous bisphosphonates on release of basic fibroblast growth factor in serum of patients with cancer-associated hypercalcemia. (12005179)
2002
32
ECM regulates MT1-MMP localization with beta1 or alphavbeta3 integrins at distinct cell compartments modulating its internalization and activity on human endothelial cells. (12427871)
2002
33
Further report of familial occurrence of collagenous colitis. (12374242)
2002
34
In vitro study of monocyte viability during the initial adhesion to albumin- and fibrinogen-coated surfaces. (11246951)
2001
35
Rhinovirus infections: induction and modulation of airways inflammation in asthma. (10421825)
1999
36
Oxidative damage and age-related macular degeneration. (10562656)
1999
37
Disseminated zygomycosis due to Rhizopus schipperae after heatstroke. (10405417)
1999
38
Apoptosis, proliferation, bax, bcl-2 and p53 status prior to and after preoperative radiochemotherapy for locally advanced rectal cancer. (9635706)
1998
39
A desensitization of hypothalamic 5-HT1A receptors by repeated injections of paroxetine: reduction in the levels of G(i) and G(o) proteins and neuroendocrine responses, but not in the density of 5-HT1A receptors. (9316875)
1997
40
Plasma total homocysteine in a representative sample of 972 British men and women aged 65 and over. (9347290)
1997
41
Anhidrotic ectodermal dysplasia associated with specific antibody deficiency. (8775234)
1996
42
A compound heterozygote for hepatic lipase gene mutations Leu334-->Phe and Thr383-->Met: correlation between hepatic lipase activity and phenotypic expression. (8732782)
1996
43
Plasma level and gene polymorphism of angiotensin-converting enzyme in relation to myocardial infarction. (8044936)
1994
44
Confirmation of the human cathepsin B gene (CTSB) assignment to chromosome 8. (1577456)
1992
45
Platelet activation by fMLP-stimulated polymorphonuclear leukocytes: the activity of cathepsin G is not prevented by antiproteinases. (1645603)
1991
46
Aortic valve replacement for ochronosis of the aortic valve. (699665)
1978
47
48
49
50

Variations for Myelitis

About this section

Expression for genes affiliated with Myelitis

About this section
Search GEO for disease gene expression data for Myelitis.

Pathways for genes affiliated with Myelitis

About this section

GO Terms for genes affiliated with Myelitis

About this section

Biological processes related to Myelitis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1positive regulation of triglyceride catabolic processGO:001089810.0APOA1, APOH
2positive regulation of lipoprotein lipase activityGO:005100610.0APOA1, APOH
3integrin-mediated signaling pathwayGO:00072299.8ITGA2B, ITGB3
4platelet degranulationGO:00025769.7APOA1, APOH
5cell adhesionGO:00071559.0ITGA2B, ITGB3, MOG

Sources for Myelitis

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet